Companies › OGEN

ORAGENICS INC (OGEN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001174940 · EDGAR filings · Updated 2026-07-07

ORAGENICS INC (OGEN) has reported institutional ownership of 4.4%, with 21 institutional managers holding positions valued at $106.3K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-07-07 — Initial insider ownership filed (Form 3)
• 2026-07-06 — Current report (8-K) filed
• 2026-05-20 — DEFA14A filed
• 2026-05-20 — Proxy statement (DEF 14A) filed
• 2026-05-19 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ORAGENICS INC has 21 institutional holders and institutional ownership of 4.4%.

Insider activity

Insiders reported 6 transactions (0 buys, 6 sells) across 2 reporting insiders, with a net reported value of −$74.4K.

Data flags from SEC filings

Related companies

Bio Green Med Solution Inc (BGMS) · BLUEJAY DIAGNOSTICS INC (BJDX) · Enveric Biosciences Inc (ENVB) · Glucotrack Inc (GCTK) · Catheter Precision Inc (VTAK) · AIM IMMUNOTECH INC (AIM)